Cerulean appoints Susan L Kelley to board
This article was originally published in Scrip
Cambridge, Massachusetts-based Cerulean Pharma has named Dr Susan L Kelley to the company's board of directors. From 2008 to 2011, Dr Kelley was chief medical officer of the Multiple Myeloma Research Consortium and its sister organization, the Multiple Myeloma Research Foundation. She also currently serves as a member of the board of directors of ArQule and Alchemia, oncology-focused biotechnology companies.